SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.140-16.2%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Strange who wrote (275)2/11/1998 8:54:00 AM
From: andy harrison  Read Replies (2) of 507
 
Rick:
If you truly believe that NVX's earnings wont surge after approval due
to the business that they will get from the CDC and from ABT selling
the product, then you are living in the bear camp. As I posted
on the IN board, I am awaiting the bear raid similar to what
happened after ORG went to the advisory panel meeting. The shorts
manipulated that stock for a couple of days but now the power of
the media is focusing on the positives of ORG. The bears will say
that they are thrilled that NVX has gotten approval so now they
can show that they wont sell any product but any one that can be
objective will realize that that statement is just plain stupid.
I will wait for the earnings to surge and then we can put the
3 years of bear doo doo to bed. NVX's pipeline, despite what the
bears say is full of billion dollar products. Their menigitis vaccines
are the only products that can protect infants under 18 months so
they have a huge potential market their. I could go on but quite
frankly..you arent worth it.

Later...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext